DE69623087T2 - Brausemittel und dessen Herstellung - Google Patents

Brausemittel und dessen Herstellung

Info

Publication number
DE69623087T2
DE69623087T2 DE69623087T DE69623087T DE69623087T2 DE 69623087 T2 DE69623087 T2 DE 69623087T2 DE 69623087 T DE69623087 T DE 69623087T DE 69623087 T DE69623087 T DE 69623087T DE 69623087 T2 DE69623087 T2 DE 69623087T2
Authority
DE
Germany
Prior art keywords
active substance
physiologically active
effervescing
effervescent
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69623087T
Other languages
English (en)
Other versions
DE69623087D1 (de
Inventor
Toshihiro Shimizu
Tetsuro Tabata
Junichi Kikuta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69623087D1 publication Critical patent/DE69623087D1/de
Application granted granted Critical
Publication of DE69623087T2 publication Critical patent/DE69623087T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
DE69623087T 1995-09-08 1996-09-06 Brausemittel und dessen Herstellung Expired - Lifetime DE69623087T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25706495 1995-09-08

Publications (2)

Publication Number Publication Date
DE69623087D1 DE69623087D1 (de) 2002-09-26
DE69623087T2 true DE69623087T2 (de) 2003-04-24

Family

ID=17301247

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69623087T Expired - Lifetime DE69623087T2 (de) 1995-09-08 1996-09-06 Brausemittel und dessen Herstellung

Country Status (5)

Country Link
US (1) US5824339A (de)
EP (1) EP0761212B1 (de)
AT (1) ATE222487T1 (de)
CA (1) CA2184964A1 (de)
DE (1) DE69623087T2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010053748A1 (de) * 2010-12-08 2012-06-14 Jörg Schierholz Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600071D0 (sv) † 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
US6365185B1 (en) * 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
CA2298823C (en) 1998-04-20 2011-06-07 Eisai Co., Ltd. Stabilized composition comprising a benzimidazole type compound
EP1121103B1 (de) * 1998-05-18 2006-12-20 Takeda Pharmaceutical Company Limited Im munde zerfallende tablette enthaltend ein benzimidazole
DK1561458T3 (da) * 1998-07-28 2010-10-25 Takeda Pharmaceutical Hurtigt henfaldende fast middel
US6667060B1 (en) * 1999-03-31 2003-12-23 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
GB9909801D0 (en) * 1999-04-28 1999-06-23 Btg Int Ltd Ultrasound detectable instrument
WO2001003707A1 (en) * 1999-07-12 2001-01-18 Smithkline Beecham Corporation Heartburn treatment
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
WO2001064189A1 (fr) * 2000-03-02 2001-09-07 Basf Aktiengesellschaft Granules revetus et compositions moussantes les contenant
AU2001275043A1 (en) 2000-05-31 2001-12-11 Drugtech Corporation Mineral supplement
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
US6558709B2 (en) 2001-01-05 2003-05-06 Howmedica Osteonics Corp. Calcium phosphate composition and method of preparing same
CA2445347C (en) * 2001-04-24 2011-09-27 Lintec Corporation An orally administered agent and an orally administered agent/supporting substrate complex
US8268333B2 (en) * 2001-04-24 2012-09-18 Lintec Corporation Orally administered agent and an orally administered agent/supporting substrate complex
JP4993652B2 (ja) * 2004-03-31 2012-08-08 リンテック株式会社 経口投与剤
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
US20040005362A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
JP2005536527A (ja) * 2002-08-02 2005-12-02 ラティオファルム ゲー・エム・ベー・ハー 微結晶セルロースと混合したベンズイミダゾール化合物を含有する医薬製剤およびその製造方法
US7048959B1 (en) 2003-01-09 2006-05-23 Kulisch Michael A Kinetic beverage for delivery of physiologically active substances
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
CA2554271A1 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
JP2005298471A (ja) * 2004-03-17 2005-10-27 Lintec Corp 薬剤の製造方法
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
CA2557848C (en) * 2004-03-30 2013-12-10 Ilypsa, Inc. Ion binding compositions
JP2005289867A (ja) * 2004-03-31 2005-10-20 Lintec Corp 経口投与剤
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
KR100627692B1 (ko) 2004-11-02 2006-09-25 (주)유라팜 Ａｃｅ 억제제 함유 제제의 제조방법 및 그 제제
US8308075B2 (en) 2005-04-19 2012-11-13 Kamterter Products, Llc Systems for the control and use of fluids and particles
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
US7311050B2 (en) * 2005-04-19 2007-12-25 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
CA2624112A1 (en) * 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
BRPI0616604A2 (pt) 2005-09-30 2012-12-25 Ilypsa Inc mÉtodo para remover e composiÇço para seletivamente remover Íon de potÁssio do trato gastrintestinal de um mamÍfero, mÉtodo para seletivamente remover Íon de potÁssio de um meio-ambiente, composiÇço farmacÊutica, partÍcula de nécleo-envoltàrio, e, usos de uma partÍcula de nécleo-envoltàrio e de uma composiÇço farmacÊutica
WO2007138606A2 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20100168410A1 (en) * 2006-10-27 2010-07-01 Pfizer Products Inc. Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
EP2086543A2 (de) 2006-10-27 2009-08-12 The Curators of the University of Missouri Zusammensetzungen mit mindestens einem säurelabilen protonenpumpen-hemmenden mittel, wahlweise anderen pharmazeutisch wirksamen mitteln und anwendungsverfahren dafür
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
US20090053367A1 (en) * 2007-05-23 2009-02-26 Michael Kulisch Kinetic Beverage for Delivery of Physiologically Active Substances
JP2011512416A (ja) 2008-02-20 2011-04-21 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法
WO2010022383A2 (en) * 2008-08-22 2010-02-25 Relypsa, Inc. Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
EP2168439B1 (de) * 2008-09-30 2011-09-21 Hitschler International GmbH & Co. KG Dragierte Brausetabletten
CN101455196B (zh) * 2008-12-23 2012-09-05 中国人民解放军海军医学研究所 一种农药泡腾组合物及其制备方法
IT1395143B1 (it) * 2009-08-06 2012-09-05 Sofar Spa Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento.
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
US8232238B2 (en) 2010-06-03 2012-07-31 The Clorox Company Concentrated film delivery systems
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
WO2017066134A1 (en) * 2015-10-16 2017-04-20 Merck Sharp & Dohme Corp. Processes for preparing formulations for gastrointestinal-targeted therapies
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CA1193870A (en) * 1980-08-14 1985-09-24 Peter N. Tomlinson Abrasive product
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
CA1266235A (en) * 1985-03-25 1990-02-27 Wallace E. Becker Tablet composition for drug combinations
CA1276017C (en) * 1986-02-13 1990-11-06 Takeda Chemical Industries, Ltd. Sulfenamide derivatives and their production
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
EP0452862B1 (de) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung
ATE191213T1 (de) * 1990-10-17 2000-04-15 Takeda Chemical Industries Ltd Pyridin-derivate, verfahren zu deren herstellung und anwendung
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
DK0592484T3 (da) * 1991-07-01 1995-06-12 Gerhard Gergely Brusetablet
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
EP0622083B1 (de) * 1993-04-28 1999-06-30 Takeda Chemical Industries, Ltd. Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung
TW280770B (de) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
ATE182073T1 (de) * 1994-03-01 1999-07-15 Gerhard Gergely Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010053748A1 (de) * 2010-12-08 2012-06-14 Jörg Schierholz Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht
DE102010053748B4 (de) 2010-12-08 2023-08-03 Jörg Schierholz Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht

Also Published As

Publication number Publication date
EP0761212A3 (de) 1997-11-12
ATE222487T1 (de) 2002-09-15
US5824339A (en) 1998-10-20
DE69623087D1 (de) 2002-09-26
EP0761212A2 (de) 1997-03-12
CA2184964A1 (en) 1997-03-09
EP0761212B1 (de) 2002-08-21

Similar Documents

Publication Publication Date Title
DE69623087D1 (de) Brausemittel und dessen Herstellung
HUT50050A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions
DK1125577T3 (da) Væskeformige medikamentindföringspræparater
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
MX9704910A (es) Formula de liberacion controlada (albuterol).
HK1046244A1 (en) Controlled release and taste masking oral pharmaceutical compositions.
NO995313D0 (no) Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
UA40634C2 (uk) Мікрокапсула, яка містить суспензію твердої біологічно активної сполуки, і спосіб її одержання
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
CA2119253A1 (en) Medication Vehicles Made of Solid Lipid Particles (Solid Lipid Nanospheres-SLN)
HUT53813A (en) Coating material controlling release of medicaments
EE200000466A (et) Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid
AU4302100A (en) Ketoprofen microgranules, method for preparing same and pharmaceutical compositions
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
GEP20022629B (en) Sustained-Release Microgranules Containing Diltiazem As The Active Principle and Gelatinous Capsule Containing the Same
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
AU668767B2 (en) Oral medicament form
GB9815801D0 (en) Liquid polymeric compositions for controlled released bioactive substances
GB2323532B (en) Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients
AR033862A1 (es) Formulacion de medicamento que contiene un agente agonista muscarinico
PT1275383E (pt) Composicao farmaceutica de libertacao modificada que contem bupropion hc1 como substancia activa

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP